The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome

HIGHLIGHTS

  • who: Teerat Sawangpanyangkura from the This cross-sectional study was reviewed and approved by the institutional Human Experimentation Committee of the Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand (Ethical approval number:, ) have published the paper: The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome, in the Journal: (JOURNAL)
  • what: This study aimed to investigate the levels of serum in MetS patients with generalized periodontitis and its association with periodontal and parameters. The studies proposed the significance of MetS as a risk factor of diabetes . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?